NASDAQ:SXTC
China SXT Pharmaceuticals, Inc.
- Stock
Last Close
0.65
25/09 14:37
Market Cap
778.80K
Beta: 0.73
Volume Today
30.45K
Avg: 502.62K
PE Ratio
−0.31
PFCF: 87.82
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Mar '16 | Mar '17 | Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | Mar '23 | Mar '24 | ||
|---|---|---|---|---|---|---|---|---|---|---|
revenue | 3.72M - | 4.88M 31.27% | 7.02M 43.79% | 7.01M 0.10% | 5.16M 26.38% | 4.78M 7.45% | 2.60M 45.53% | 1.97M 24.23% | 1.93M 2.19% | |
cost of revenue | 2.92M - | 2.57M 12.14% | 3.62M 40.79% | 2.40M 33.65% | 2.46M 2.42% | 1.94M 21.17% | 1.35M 30.31% | 1.55M 14.42% | 1.37M 11.06% | |
gross profit | 793.99K - | 2.31M 191.19% | 3.40M 47.12% | 4.61M 35.57% | 2.70M 41.37% | 2.84M 5.02% | 1.25M 55.92% | 426.27K 65.94% | 553.97K 29.96% | |
selling and marketing expenses | 151.03K - | 144.36K 4.41% | 512.48K 254.99% | 1.61M 213.28% | 1.58M 1.38% | 1.59M 0.26% | 924.54K 41.76% | 387.45K 58.09% | ||
general and administrative expenses | 433.82K - | 565.46K 30.34% | 1.26M 122.25% | 1.24M 1.61% | 2.46M 99.07% | 3.45M 40.13% | 5.52M 59.94% | 5.65M 2.35% | ||
selling general and administrative expenses | 584.85K - | 709.82K 21.37% | 1.77M 149.25% | 2.84M 60.64% | 4.04M 42.32% | 5.04M 24.52% | 6.44M 27.89% | 6.03M 6.33% | 2.46M 59.20% | |
research and development expenses | 184.19K - | |||||||||
other expenses | 18.40K - | -3.80K 120.67% | 27.14K 813.67% | -73.77K 371.81% | 871.65K 1,281.56% | -181.58K 120.83% | 149.51K 182.34% | |||
cost and expenses | 3.51M - | 3.28M 6.56% | 5.39M 64.27% | 5.24M 2.68% | 6.50M 24.05% | 6.97M 7.25% | 7.79M 11.72% | 7.58M 2.73% | 4.02M 46.95% | |
operating expenses | 584.85K - | 709.82K 21.37% | 1.77M 149.25% | 2.84M 60.64% | 4.04M 42.32% | 5.04M 24.52% | 6.44M 27.89% | 6.03M 6.33% | 2.65M 56.14% | |
interest expense | 779 - | -5.17K 763.67% | -3.35M 64,673.50% | -1.62M 51.76% | 218.28K 113.51% | 476.78K 118.43% | 544.28K 14.16% | |||
ebitda | 298.10K - | 1.70M 470.75% | 1.76M 3.32% | 1.95M 10.95% | 4.62M 136.70% | -1.85M 140.11% | -4.87M 162.99% | -5.36M 10.01% | -1.89M 64.74% | |
operating income | 209.14K - | 1.60M 666.08% | 1.63M 1.88% | 1.77M 8.41% | 4.28M 142.15% | -2.20M 151.28% | -5.19M 136.21% | -5.61M 8.05% | -2.09M 62.69% | |
depreciation and amortization | 88.96K - | 99.23K 11.54% | 129.44K 30.45% | 180.92K 39.77% | 331.84K 83.42% | 345.41K 4.09% | 320.01K 7.36% | 250.16K 21.83% | 203.25K 18.75% | |
total other income expenses net | -20.41K - | 18.40K 190.14% | -3.80K 120.67% | 27.14K 813.67% | -14.67M 54,167.25% | -743.79K 94.93% | -218.28K 70.65% | 149.51K 168.50% | -1.01M 773.01% | |
income before tax | 188.72K - | 1.58M 737.30% | 1.63M 3.01% | 1.79M 10.06% | -10.39M 679.95% | -2.94M 71.69% | -5.41M 83.89% | -5.93M 9.74% | -3.10M 47.79% | |
income tax expense | 47.18K - | 395.05K 737.31% | 440.10K 11.40% | 252.23K 42.69% | -101.72K 140.33% | -192.68K 89.42% | 328.15K 270.30% | 476.78K 45.29% | 3 100.00% | |
net income | 141.54K - | 1.19M 737.30% | 1.19M 0.21% | 1.54M 29.61% | -10.29M 768.38% | -2.75M 73.29% | -5.74M 108.72% | -5.93M 3.46% | -3.10M 47.79% | |
weighted average shs out | 250K - | 296.88K 18.75% | 296.88K 0% | 257.11K 13.40% | 309.11K 20.23% | 719.55K 132.78% | 1.04M 44.50% | 1.04M 0% | 867.42K 16.58% | |
weighted average shs out dil | 250K - | 296.88K 18.75% | 296.88K 0% | 257.11K 13.40% | 309.11K 20.23% | 719.55K 132.78% | 1.04M 44.50% | 1.04M 0% | 867.42K 16.58% | |
eps | 0.57 - | 3.99 600.00% | 4 0.25% | 5.99 49.75% | -33.28 655.59% | -3.82 88.52% | -5.52 44.50% | -5.71 3.44% | -3.57 37.48% | |
epsdiluted | 0.57 - | 3.99 600.00% | 4 0.25% | 5.99 49.75% | -33.28 655.59% | -3.82 88.52% | -5.52 44.50% | -5.71 3.44% | -3.57 37.48% |
All numbers in USD (except ratios and percentages)